Loading…

Rockwell Medical extended its product purchase agreement with DaVita Inc. through December 31, 2026, including a price increase on its hemodialysis products.
“The amended agreement, extended through December 31, 2026, not only secures a key revenue stream for Rockwell but also includes a favorable price increase on its products for the duration of the term.”briefglance.com
Summarized from public sources; check the original articles before acting on it.